South Korea
· Delayed Price · Currency is KRW Genic Statistics
Total Valuation
Genic has a market cap or net worth of KRW 129.11 billion. The enterprise value is 135.49 billion.
| Market Cap | 129.11B |
| Enterprise Value | 135.49B |
Important Dates
The last earnings date was Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Genic has 7.82 million shares outstanding. The number of shares has decreased by -0.18% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 7.82M |
| Shares Change (YoY) | -0.18% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | n/a |
| Float | 4.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.91 |
| PB Ratio | 9.65 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -57.19 |
| EV / Sales | 4.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -82.06 |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.86.
| Current Ratio | 0.93 |
| Quick Ratio | 0.56 |
| Debt / Equity | 0.86 |
| Debt / EBITDA | n/a |
| Debt / FCF | -6.14 |
| Interest Coverage | -4.84 |
Financial Efficiency
Return on equity (ROE) is -18.38% and return on invested capital (ROIC) is -5.78%.
| Return on Equity (ROE) | -18.38% |
| Return on Assets (ROA) | -4.57% |
| Return on Capital (ROIC) | -5.78% |
| Revenue Per Employee | 153.12M |
| Profits Per Employee | -12.53M |
| Employee Count | 189 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 4.69 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +373.97% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +373.97% |
| 50-Day Moving Average | 17,775.80 |
| 200-Day Moving Average | 7,073.10 |
| Relative Strength Index (RSI) | 38.70 |
| Average Volume (20 Days) | 251,275 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genic had revenue of KRW 28.94 billion and -2.37 billion in losses. Loss per share was -345.84.
| Revenue | 28.94B |
| Gross Profit | 3.44B |
| Operating Income | -2.00B |
| Pretax Income | -2.37B |
| Net Income | -2.37B |
| EBITDA | -346.69M |
| EBIT | -2.00B |
| Loss Per Share | -345.84 |
Balance Sheet
The company has 3.76 billion in cash and 10.14 billion in debt, giving a net cash position of -6.38 billion or -815.26 per share.
| Cash & Cash Equivalents | 3.76B |
| Total Debt | 10.14B |
| Net Cash | -6.38B |
| Net Cash Per Share | -815.26 |
| Equity (Book Value) | 11.72B |
| Book Value Per Share | 1,709.62 |
| Working Capital | -1.15B |
Cash Flow
In the last 12 months, operating cash flow was -1.44 billion and capital expenditures -208.14 million, giving a free cash flow of -1.65 billion.
| Operating Cash Flow | -1.44B |
| Capital Expenditures | -208.14M |
| Free Cash Flow | -1.65B |
| FCF Per Share | -211.00 |
Margins
Gross margin is 11.88%, with operating and profit margins of -6.91% and -8.19%.
| Gross Margin | 11.88% |
| Operating Margin | -6.91% |
| Pretax Margin | -8.19% |
| Profit Margin | -8.19% |
| EBITDA Margin | -1.20% |
| EBIT Margin | -6.91% |
| FCF Margin | -5.70% |
Dividends & Yields
Genic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.18% |
| Shareholder Yield | 0.18% |
| Earnings Yield | -2.10% |
| FCF Yield | -1.28% |
Stock Splits
The last stock split was on December 27, 2017. It was a forward split with a ratio of 1.0103113.
| Last Split Date | Dec 27, 2017 |
| Split Type | Forward |
| Split Ratio | 1.0103113 |
Scores
Genic has an Altman Z-Score of 0.94. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.94 |
| Piotroski F-Score | n/a |